These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37889184)

  • 1. Simultaneous evaluation of the fractional exhaled nitric oxide and blood eosinophil count of T2-high endotype in patients with non-cystic fibrosis bronchiectasis.
    Chen F; Zeng Z; Huang X; Liu Y
    Chron Respir Dis; 2023; 20():14799731231210559. PubMed ID: 37889184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type 2 Biomarkers and Their Clinical Implications in Bronchiectasis: A Prospective Cohort Study.
    Chen YF; Hou HH; Chien N; Lu KZ; Chen YY; Hung ZC; Chien JY; Wang HC; Yu CJ
    Lung; 2024 Oct; 202(5):695-709. PubMed ID: 38884647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 2 Low Biomarker Stability and Exacerbations in Severe Uncontrolled Asthma.
    Viinanen A; Aakko J; Lassenius MI; Telg G; Nieminen K; Kaijala S; Lehtimäki L; Kankaanranta H
    Biomolecules; 2023 Jul; 13(7):. PubMed ID: 37509154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between pre-biologic T2-biomarker combinations and response to biologics in patients with severe asthma.
    Porsbjerg CM; Townend J; Bergeron C; Christoff GC; Katsoulotos GP; Larenas-Linnemann D; Tran TN; Al-Lehebi R; Bosnic-Anticevich SZ; Busby J; Hew M; Kostikas K; Papadopoulos NG; Pfeffer PE; Popov TA; Rhee CK; Sadatsafavi M; Tsai MJ; Ulrik CS; Al-Ahmad M; Altraja A; Beastall A; Bulathsinhala L; Carter V; Cosio BG; Fletton K; Hansen S; Heaney LG; Hubbard RB; Kuna P; Murray RB; Nagano T; Pini L; Cano Rosales DJ; Schleich F; Wechsler ME; Amaral R; Bourdin A; Brusselle GG; Chen W; Chung LP; Denton E; Fonseca JA; Hoyte F; Jackson DJ; Katial R; Kirenga BJ; Koh MS; Ławkiedraj A; Lehtimäki L; Liew MF; Mahboub B; Martin N; Menzies-Gow AN; Pang PH; Papaioannou AI; Patel PH; Perez-De-Llano L; Peters MJ; Ricciardi L; Rodríguez-Cáceres B; Solarte I; Tay TR; Torres-Duque CA; Wang E; Zappa M; Abisheganaden J; Assing KD; Costello RW; Gibson PG; Heffler E; Máspero J; Nicola S; Perng Steve DW; Puggioni F; Salvi S; Sheu CC; Sirena C; Taillé C; Tan TL; Bjermer L; Canonica GW; Iwanaga T; Jiménez-Maldonado L; Taube C; Brussino L; Price DB
    Front Immunol; 2024; 15():1361891. PubMed ID: 38711495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eosinophilic Bronchiectasis: Prevalence, Severity, and Associated Features-A Cohort Study.
    Campisi R; Nolasco S; Mancuso M; Spinella M; Vignera F; Crimi N; Vancheri C; Crimi C
    J Clin Med; 2024 Aug; 13(16):. PubMed ID: 39201075
    [No Abstract]   [Full Text] [Related]  

  • 6. Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations.
    Price DB; Bosnic-Anticevich S; Pavord ID; Roche N; Halpin DMG; Bjermer L; Usmani OS; Brusselle G; Ming SWY; Rastogi S
    Clin Transl Allergy; 2019; 9():41. PubMed ID: 31452870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T2-High Endotype and Response to Biological Treatments in Patients with
    Oriano M; Gramegna A; Amati F; D'Adda A; Gaffuri M; Contoli M; Bindo F; Simonetta E; Di Francesco C; Santambrogio M; Sotgiu G; Blasi F; Aliberti S
    Biomedicines; 2021 Jul; 9(7):. PubMed ID: 34356836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implication of fraction of exhaled nitric oxide and blood eosinophil count in severe asthma.
    Soma T; Iemura H; Naito E; Miyauchi S; Uchida Y; Nakagome K; Nagata M
    Allergol Int; 2018 Sep; 67S():S3-S11. PubMed ID: 29754974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Fractional Exhaled Nitric Oxide in Diagnosing Asthmatic Type 2 Chronic Rhinosinusitis With Nasal Polyps.
    Park JA; Cha H; Yang SK; Ryu HT; Kim DW; Hong SN; Yang MS; Kim DW
    Am J Rhinol Allergy; 2023 Sep; 37(5):524-530. PubMed ID: 37160729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nationwide survey of refractory asthma with bronchiectasis by inflammatory subtypes.
    Nomura N; Matsumoto H; Yokoyama A; Nishimura Y; Asano K; Niimi A; Tohda Y; Harada N; Nagase H; Nagata M; Inoue H; Kondo M; Horiguchi T; Miyahara N; Hizawa N; Hojo M; Hattori N; Hashimoto N; Yamasaki A; Kadowaki T; Kimura T; Miki M; Taniguchi H; Toyoshima M; Kawamura T; Matsuno O; Sato Y; Sunadome H; Nagasaki T; Oguma T; Hirai T;
    Respir Res; 2022 Dec; 23(1):365. PubMed ID: 36539765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Relationship of Fractional Exhaled Nitric Oxide in Patients with AECOPD.
    Xu X; Zhou L; Tong Z
    Int J Chron Obstruct Pulmon Dis; 2023; 18():3037-3046. PubMed ID: 38146507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers for predicting type 2-high and uncontrolled asthma in real-world practice.
    Woo SD; Park HS; Jang JH; Lee Y; Yang EM; Ban GY; Kim SH; Shin YS; Ye YM; Park HS
    Ann Allergy Asthma Immunol; 2023 Aug; 131(2):209-216.e2. PubMed ID: 37209833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utility of fractional exhaled nitric oxide and blood eosinophils counts in the diagnosis of asthma-COPD overlap.
    Takayama Y; Ohnishi H; Ogasawara F; Oyama K; Kubota T; Yokoyama A
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2525-2532. PubMed ID: 30174422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fractional Exhaled Nitric Oxide is Associated with the Severity of Stable COPD.
    Liu X; Zhang H; Wang Y; Lu Y; Gao Y; Lu Y; Zheng C; Yin D; Wang S; Huang K
    COPD; 2020 Apr; 17(2):121-127. PubMed ID: 32116037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic possibility of the combination of exhaled nitric oxide and blood eosinophil count for eosinophilic asthma.
    Li JH; Han R; Wang YB; Cheng M; Chen HY; Lei WH; Li L; Gao C; Zhao NN; Nie NF; Li ZY; Yin GQ; Huang S; He Y
    BMC Pulm Med; 2021 Aug; 21(1):259. PubMed ID: 34372824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneously increased fraction of exhaled nitric oxide levels and blood eosinophil counts relate to increased asthma morbidity.
    Malinovschi A; Janson C; Borres M; Alving K
    J Allergy Clin Immunol; 2016 Nov; 138(5):1301-1308.e2. PubMed ID: 27113848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Sputum Eosinophilia With Easily Measured Type-2 Inflammatory Biomarkers in Untreated Mild Persistent Asthma.
    Covar R; Lazarus SC; Krishnan JA; Blake KV; Sorkness CA; Dyer AM; Lang JE; Lugogo NL; Mauger DT; Wechsler ME; Wenzel SE; Cardet JC; Castro M; Israel E; Phipatanakul W; King TS;
    J Allergy Clin Immunol Pract; 2024 Apr; 12(4):960-969.e6. PubMed ID: 38097180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between total serum immunoglobulin E levels, fractional exhaled breath nitric oxide levels and absolute blood eosinophil counts in atopic and non-atopic asthma: a controlled comparative study.
    Shrestha SK; Drews A; Sharma L; Pant S; Shrestha S; Neopane A
    J Breath Res; 2018 Feb; 12(2):026009. PubMed ID: 29068321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of eosinophil counts in induced sputum and fractional concentration of exhaled nitric oxide and lung functions in patients with mild to moderate asthma.
    Wang W; Huang KW; Wu BM; Wang YJ; Wang C
    Chin Med J (Engl); 2012 Sep; 125(17):3157-60. PubMed ID: 22932198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type-2 airway inflammation in mild asthma patients with high blood eosinophils and high fractional exhaled nitric oxide.
    Southworth T; Van Geest M; Singh D
    Clin Transl Sci; 2021 Jul; 14(4):1259-1264. PubMed ID: 34106513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.